These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24507535)

  • 1. Future treatment approaches to multiple sclerosis.
    Derwenskus J; Lublin FD
    Handb Clin Neurol; 2014; 122():563-77. PubMed ID: 24507535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-modifying agents in multiple sclerosis.
    O'Connor PW; Oh J
    Handb Clin Neurol; 2014; 122():465-501. PubMed ID: 24507532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of MS.
    Vosoughi R; Freedman MS
    Clin Neurol Neurosurg; 2010 Jun; 112(5):365-85. PubMed ID: 20362388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current disease-modifying treatment of multiple sclerosis.
    Derwenskus J
    Mt Sinai J Med; 2011; 78(2):161-75. PubMed ID: 21425262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis.
    Fox EJ; Rhoades RW
    Curr Opin Neurol; 2012 Feb; 25 Suppl():S11-9. PubMed ID: 22398660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis - established and novel therapeutic approaches.
    Ehling R; Berger T; Reindl M
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drug therapies for multiple sclerosis.
    Mangas A; Coveñas R; Geffard M
    Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of pediatric multiple sclerosis.
    Yeh EA; Weinstock-Guttman B
    J Child Neurol; 2012 Nov; 27(11):1384-93. PubMed ID: 22914373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
    Fernandez O; Alvarez-Cermeno JC; Arroyo-Gonzalez R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; de las Heras V; Garcia-Merino JA; Hernandez-Perez MA; Izquierdo G; Meca-Lallana JE; Munoz-Garcia D; Olascoaga J; Oreja-Guevara C; Prieto JM; Ramio-Torrenta L; Rodriguez-Antiguedad A; Romero-Pinel L; Sanchez F; Tellez N; Tintore M; Montalban X;
    Rev Neurol; 2012 Jun; 54(12):734-49. PubMed ID: 22673950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New and emerging treatments for multiple sclerosis].
    Louapre C; Maillart É; Papeix C; Lubetzki C
    Med Sci (Paris); 2013 Dec; 29(12):1105-10. PubMed ID: 24356140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies.
    Ulzheimer JC; Meuth SG; Bittner S; Kleinschnitz C; Kieseier BC; Wiendl H
    BioDrugs; 2010 Aug; 24(4):249-74. PubMed ID: 20623991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM; Rainka MM; Patel MJ; Gengo FM
    Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving therapies for multiple sclerosis.
    Korniychuk E; Dempster JM; O'Connor E; Alexander JS; Kelley RE; Kenner M; Menon U; Misra V; Hoque R; Gonzalez-Toledo E; Schwendimann RN; Smith S; Minagar A
    Int Rev Neurobiol; 2007; 79():571-88. PubMed ID: 17531859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis therapeutic pipeline: opportunities and challenges.
    Krieger S
    Mt Sinai J Med; 2011; 78(2):192-206. PubMed ID: 21425264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies.
    Meuth SG; Bittner S; Ulzheimer JC; Kleinschnitz C; Kieseier BC; Wiendl H
    BioDrugs; 2010 Oct; 24(5):317-30. PubMed ID: 20795753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on therapeutic options for multiple sclerosis.
    McCoyd M
    Neurol Clin; 2013 Aug; 31(3):827-45. PubMed ID: 23896508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D
    Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.